DuoVisc Solution Ophthalmic Viscoelastic System (OVD) 0.35V-0.4P

DuoVisc® Ophthalmic Viscoelastic System (OVD), 0.35 mL VISCOAT® + 0.40 mL PROVISC® — Alcon

NDC: 08065-1831-35

Product Details

Product Name	DuoVisc® Ophthalmic Viscoelastic System
Components	One 0.35 mL VISCOAT® syringe and one 0.40 mL PROVISC® syringe
Active Ingredients	VISCOAT®: Sodium chondroitin sulfate 4% (40 mg/mL) and sodium hyaluronate 3% (30 mg/mL). PROVISC®: Sodium hyaluronate.
Dosage Form	Sterile ophthalmic viscoelastic solutions
Route	Intraocular use during ophthalmic surgery
Manufacturer	Alcon
NDC	08065-1831-35

Indications and Usage

DuoVisc® is indicated for use as an ophthalmic surgical aid during anterior segment procedures, including cataract extraction and intraocular lens (IOL) implantation. The system combines VISCOAT® dispersive ophthalmic viscoelastic device (OVD) for corneal endothelial protection with PROVISC® cohesive OVD for anterior chamber maintenance and space creation during surgery.

Dosage and Administration

For use by qualified ophthalmic surgeons during anterior segment procedures. The products may be used sequentially or according to the surgical technique. Follow the manufacturer's instructions for use for administration and removal.

Warnings and Precautions

• For intraocular surgical use by qualified ophthalmic professionals only.
• Follow the manufacturer's instructions for assembling and using the supplied cannulas. Incorrect assembly or use of an alternate cannula may result in cannula detachment and potential patient injury.
• Thoroughly remove the viscoelastic materials as directed at the end of the procedure to help minimize postoperative increases in intraocular pressure.
• Use caution in patients with known hypersensitivity to product components or biological materials.

Contraindications

Refer to the manufacturer's complete instructions for use for specific contraindications and precautions.

Adverse Reactions

A transient increase in intraocular pressure may occur during the early postoperative period. Other potential risks may be associated with intraocular surgery and the use of ophthalmic viscoelastic devices. Refer to the complete instructions for use for additional safety information.

Storage and Handling

Store refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Follow the storage and handling instructions provided on the manufacturer's packaging.

How Supplied

DuoVisc® is supplied as a sterile, single-use ophthalmic viscoelastic system containing one 0.35 mL VISCOAT® syringe and one 0.40 mL PROVISC® syringe.

NDC: 08065-1831-35

---

Professional use only.

Clinical information is summarized from Alcon product information. Refer to the manufacturer's complete instructions for use for full indications, warnings, precautions, and handling details.

If you have questions related to DSCSA compliance, transaction history, regulatory data, or quality assurance, please contact our team at compliance@dryeyerescue.com.